GlobalData on MSN3d
FDA approves Azurity Pharmaceuticals’ Danziten for CML treatmentThe US Food and Drug Administration (FDA) has approved Azurity Pharmaceuticals’ Danziten (nilotinib), the first and only ...
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback